The newly acquired Singapore-based company has completed the fully automated plant expansion
Image credit: Puritas Asgard
Puritas Asgard has successfully completed the detailed design, supply and installation of a new, state-of-the-art API facility extension cleanroom project in Singapore.
The facility will manufacture APIs critical for critical medications and life-saving drugs.
The fully automated plant consists of a general-purpose organic synthesis plant (OSP), which incorporates state-of-the-art API manufacturing technologies. In addition, there are also advanced process control systems, business and IT systems, and environmental protection technologies in place to ensure the optimal running of operations.
"Puritas Asgard were delighted to play a part in the delivery of such an important facility," the company stated.
Puritas was acquired in late 2022 by Asgard, becoming an Asgatech company.